ALPHA TRIBE

Sakar Healthcare LimitedUpdates, 11-11-2025: General Updates

11-11-2025 | 11:25 am

Sakar Healthcare announced the financial results for the quarter and half-year. Revenue for Q2 grew 34.6% YoY to ₹57.56 Cr, and H1 revenue rose 31.4% to ₹110.30 Cr. H1 PAT increased 27.8% to ₹9.21 Cr. The company's strategic focus remains on oncology, with 55 molecules developed.

No comments yet. Be the first to comment!

All announcements from Sakar Healthcare Limited